About cookies

Cookies help us improve our online service and improve its content and accessibility. Some cookies are necessary for the pages to work properly. You can accept all cookies or only those that are necessary. You can change the settings by clicking Cookie settings.

Cookie settings

Cookie settings

With the help of cookies, we develop our online service and improve its content and accessibility. Some cookies are necessary for the functionality of the pages.

You can enable the cookies you want by checking the boxes below. After making your selections, click Save and Close. The online service works even if you do not allow any necessary cookies. However, some differences may occur.

The necessary cookies are automatically stored on your browser when you use our web service. These cookies are used to ensure that the fimea.fi web service functions as intended.

The web analytics tool Snoobi helps us understand how our customers use the fimea.fi web service and where they come from.

We use the Siteimprove service to monitor the accessibility of pages, the functionality of links and the finding of pages on search engines.

Skip to Content
fimea.fi front page fimea.fi front page

SearchBar

Select search type
Move to advanced medicine search
Suomi
Svenska
EN
Contact Information
fimea.fi front page fimea.fi front page
Suomi
Svenska
EN
  •   For public
  •   Current events
  •   Databases and registers
  •   Development and HTA
  •   Marketing authorisations
  •   Medical devices
  •   Pharmaceutical safety and information
  •   Pharmacies
  •   Supervision
  •   Veterinary
  •   About us
    • Contact us
    • Open positions
    • Forms
    • Organisation
    • Publications
    • Fees
    • Estimated processing times
    • Data requests
    • Data access authorisations
    • Open data
    • Frequently asked questions
      • Clinical drug trials
      • Generic medicines
      • Invoicing
      • Marketing authorisations
      • Narcotics control
      • New EudraVigilance -system
  • Front page
  • About us
  • Frequently asked questions
  • Generic medicines

Generic medicines

Suomeksi På svenska

Frequently asked questions

  • What are generic medicines?
  • When do generic medicines become available?
  • How can marketing authorisation be obtained for generic medicines?
  • Are generic medicines too easy to develop?
  • Are generic medicines the same quality as reference medicines?
  • What are the benefits of generic medicines to the patient?
  • Can the generic medicine or the ingredients used in it originate in China or India?
  • Why do generic medicines look different from the reference medicine?
  • How much cheaper are generic medicines?
  • What are the benefits to society?
  • Will the development of new innovative medicines stop when patents expire and the cost of medicines falls?
  • Have generic medicines already generated cost benefits?
  • Are the Finnish authorities responsible for monitoring generic medicines that have been granted marketing authorisation in another EU member state?
  • Why does the information provided in the package leaflet vary between generic products?
  • What are parallel imports?
  • Is marketing authorisation required for parallel imports?
  • What is parallel distribution?
Page 1
1
Previous
Previous
Next
Next
RSS (Opens New Window)(Opens New Window)
Print

Site information

  • About us

Quicklinks

  • Whats new
  • Contact
  • Contact information

Follow us

  • Linkedin Linkedin

Home fimea.fi Home fimea.fi